Data / Form D filings / ENCOMPASS TECHNOLOGIES, INC.
ENCOMPASS TECHNOLOGIES, INC.: Form D filings
ENCOMPASS TECHNOLOGIES, INC., a biotechnology company in Carson City, NV, filed 4 Form D notices with the SEC between 2020 and 2025. The latest, on May 19, 2025, reports $40.3 million sold of a $60.3 million offering to 5 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 2730 N. Deer Run Rd, Carson City, NV, 89701
- Phone
- (949) 422-9240
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1816168
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 19, 2025 | New notice | $60,251,387 | $40,251,391 | $19,999,996 | 5 | Apr 7, 2025 | sec.gov |
| Nov 20, 2023 | New notice | $10,000,000 | $2,000,000 | $8,000,000 | 1 | Nov 9, 2023 | sec.gov |
| Aug 8, 2022 | New notice | $8,000,000 | $2,000,000 | $6,000,000 | 1 | Mar 30, 2022 | sec.gov |
| Jun 25, 2020 | New notice | $6,000,000 | $4,000,000 | $2,000,000 | 10 | Jun 12, 2020 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| William Starling | Director | |
| Christopher Martin | Director | |
| George Wallace | Executive Officer, Director | |
| Steven Gex | Director | |
| J.Avi Roop | Director |
Other biotechnology companies in Nevada that filed recently
- Palimpsest Bio Corp. $172,000 · Oct 30, 2026
- Conexeu Sciences Inc. $1.5 million · Oct 21, 2026
Every Form D from the week of May 19, 2025 · All recent filings in Nevada · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what ENCOMPASS TECHNOLOGIES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.